Valuation Gilead Sciences, Inc. Berne S.E.

Stocks

End-of-day quote Berne S.E. Other stock markets 2026-02-10			5-day change	1st Jan Change
115.86 ^CHF	+69.18%		+57.76%	+69.18%

07-16	Kalshi to allow bets on clinical trials, FDA decisions	RE
07-15	African markets - factors to watch on July 15	RE

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	91,081	107,677	100,942	115,118	152,281	166,718	-	-
Change	-	18.22%	-6.25%	14.04%	32.28%	9.48%	-	-
Enterprise Value (EV) ¹	118,530	126,522	118,665	131,838	169,585	176,178	166,718	156,625
Change	-	6.74%	-6.21%	11.1%	28.63%	3.89%	-5.37%	-6.05%
P/E	14.7x	23.6x	18x	243x	18.1x	-48.4x	17x	15.6x
PBR	4.32x	5.05x	4.48x	5.98x	6.73x	8.47x	6.62x	5.34x
PEG	-	-0.9x	0.8x	-2.7x	0x	0x	-0x	1.74x
Capitalization / Revenue	3.34x	3.95x	3.72x	4x	5.17x	5.47x	5.15x	4.88x
EV / Revenue	4.34x	4.64x	4.38x	4.59x	5.76x	5.78x	5.15x	4.58x
EV / EBITDA	8.12x	8.86x	9.01x	11.7x	10.6x	32x	9.26x	8.69x
EV / EBIT	9.45x	10.4x	11.3x	15.5x	12.9x	64x	10.7x	9.36x
EV / FCF	11x	15.2x	16x	12.8x	17.9x	173x	12.6x	11.2x
FCF Yield	9.12%	6.59%	6.25%	7.82%	5.58%	0.58%	7.94%	8.94%
Dividend per Share ²	2.84	2.92	3	3.08	3.16	3.246	3.362	3.099
Rate of return	3.91%	3.4%	3.7%	3.33%	2.57%	2.42%	2.5%	2.31%
EPS ²	4.93	3.64	4.5	0.38	6.78	-2.776	7.879	8.587
Distribution rate	57.6%	80.2%	66.7%	811%	46.6%	-117%	42.7%	36.1%
Net sales ¹	27,305	27,281	27,116	28,754	29,443	30,469	32,399	34,175
EBITDA ¹	14,598	14,283	13,177	11,287	15,953	5,514	18,005	18,023
EBIT ¹	12,548	12,180	10,484	8,520	13,193	2,754	15,632	16,730
Net income ¹	6,225	4,592	5,665	480	8,510	-3,391	9,762	10,457
Net Debt ¹	27,449	18,845	17,723	16,720	17,304	9,460	-	-10,093
Reference price ²	72.61	85.85	81.01	92.37	122.74	134.28	134.28	134.28
Nbr of stocks (in thousands)	1,254,384	1,254,244	1,246,042	1,246,266	1,240,680	1,241,570	-	-
Announcement Date	2/1/22	2/2/23	2/6/24	2/11/25	2/10/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	34.75x	12.42x	25.87x	0.58%	1,043B
JOHNSON & JOHNSON	26.86x	6.13x	16.78x	2.15%	602B
ABBVIE INC.	33.14x	7.52x	15.43x	2.7%	449B
ROCHE HOLDING AG	17.71x	4.39x	10.82x	3.02%	327B
NOVARTIS AG	21.31x	5.47x	13.24x	2.89%	279B
ASTRAZENECA PLC	21.26x	4.48x	12.39x	1.96%	264B
AMGEN INC.	24.37x	6.42x	11.35x	2.71%	201B
PFIZER INC.	12.77x	3.12x	7.88x	6.86%	143B
VERTEX PHARMACEUTICALS INCORPORATED	27.8x	8.4x	18.93x	-.--%	123B
Average	24.44x	6.48x	14.74x	2.54%	381.24B
Weighted average by Cap.	27.63x	7.85x	17.56x	2.03%